Synthetic Peptides Market Growth is Supported by Increasing Prevalence of Metabolic Disorders

Peptides are made up of chains of amino acid, linked with the peptide bond. Dipeptide are made of two amino acid, tripeptide are made of three amino acids and polypeptide are long, unbranched chain of amino acid joined by peptide bonds. Chain of amino acid up to 50 amino acid are known as peptides, greater than 50 amino acid is known as proteins. Peptides are used as a therapeutic agent, in the treatment of various disease condition, as peptides performs many metabolic functions in the body.  Adequate amount of amino acid are necessary in the body to produce various hormones necessary for body functioning. Synthetic peptide are artificially produced outside the cell with the help of chemical reactions. Synthetic peptide are used for research purpose by various pharmaceutical and biotechnological companies. Due to the emergence of peptide synthesis, variety of antibody can be prepared involving new therapeutic technique used for biological research, drug discovery, and product development.

Browse Report for more Details: http://www.transparencymarketresearch.com/synthetic-peptides-market.html

Several companies are involved in generation of synthetic peptide, they provide special set of products and services. Peptide libraries are maintained by various companies that help in development of vaccines, drug screening, sequencing of amino acid for research activities and others. These days peptides are available as drugs, and various peptide drug candidates are under clinical trials that has the potential to address therapeutic challenges. Natural peptides are rapidly metabolized, and has low oral bioavailability, the concept that it cannot be orally available has contributed to the revival of interest in peptides as drug candidate by some of the pharmaceutical company.

New strategies are adopted by scientists and researchers to lower the metabolism of the peptide by demonstrating alternative routes of administration, improve productivity so that large number of peptide- based drugs are available in the market. Synthetic peptide vaccine is a promising alternative approach to immunization that will fuel growth of the global synthetic peptide marker in the near future.

The invention of peptide synthesis has unlocked different application area in which synthetic peptides are used as therapeutic agent, used to study protein characterization, establish enzyme substrate reaction within different enzyme classes that demonstrate essential role in cell signaling. It also plays a central role in mass spectrometry-based drug discovery, quantitation of proteins during biomarker study in early drug discovery and development.

Synthetic Peptide Market: Drivers and Restrains

Increased demand for research and development for early detection and diagnosis of disease, increased expenditure on healthcare sector, increasing prevalence of cardiovascular disease and metabolic disorders, advancements in synthetic peptides vaccines due to high specificity, increased number of synthetic peptide clinical trials, technological advancement in the diagnostic and treatment process of infectious diseases, advancement in molecular techniques are some of the factors fuelling the growth of the global synthetic peptide market. Various factors such as low oral bioavailability of peptide drugs, short half-life, rapid metabolism, patent expiration, high development and commercialization cost are some factors inhibiting the growth of synthetic peptide market.

The synthetic peptide market is segment based on application, route of administration, marketing status, distribution channel and geography. Based on the application type synthetic peptide market is segmented as oncology, cardiovascular, metabolic disorders, hematological disorders, gastrointestinal disorders, respiratory disorders, dermatology and others. On the basis of route of administration, the synthetic peptide market is segmented into parenteral and oral. Based on marketing status the market is segmented as branded and generics. Based on distribution channel, the synthetic peptide market is segmented into hospital pharmacy, retail pharmacy, drug stores, and online pharmacy. Increase in the number of patient population will lead to rise in the diagnostic procedures, growing demand for early diagnosis of rare disease will reduce the healthcare cost burden. Growth opportunities such as increasing market share through mergers and acquisitions and investing in emerging economics, development of advanced generic version of synthetic peptide drugs are some of the factors boosting the growth of the synthetic peptide market.

Synthetic Peptide Market: Regional Overview

Region wise, the synthetic peptide market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is estimated to account for major share followed by European countries. Mainly the U.S. & European markets, owing to its innate nature of developed healthcare infrastructure, adopts advanced technology at early stage as compared to developing economies, high pricing of drugs, increase in incidence of lifestyle diseases, that follows large patient pool  etc. is estimated to maintain its leadership geographically . Significant economic development has led to an increase in healthcare availability in Asia Pacific region, growing number of multi-specialty clinics and hospitals and penetration of global players in Asia is expected to fuel demand for synthetic peptide for research and development and advancing the diagnostic and treatment process.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25949

Synthetic Peptide Market: Key Players

Some of the key players in global synthetic peptide market are Thermo Fisher Scientific, Inc., AstraZeneca plc., Bachem Holding AG , Novo Nordisk A/S, Merck & Co., Inc., Eli Lilly and Company, Ipsen S.A, Teva Pharmaceutical Industries Ltd, C.R. Bard, Gelita Medical AG, Pfizer Inc. Ocular Therapeutix and others

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/